Cardiology

Filter

New Research into Oral Semaglutide and Heart Failure Outcomes

February 2026

The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.

EACVI/ESC Scientific Statement: Improving Women’s Cardiovascular Care with Tailored Imaging

Exploring how cardiovascular imaging can better address the unique risks and outcomes of heart disease in women.

New siRNA Therapy Cuts Triglycerides by 57% in Severe Hypertriglyceridemia

Plozasiran significantly reduced triglycerides by 57% in severe hypertriglyceridemia, showing promise as a new treatment option.

Festive Replay: 2024's Healthcare Highlights Part 2

As 2024 comes to a close, join EMJ Editor, Evgenia Koutsouki as she counts down the standout moments from the past year in the second and final instalment of our Highlights series.

Triple Single-Pill Lowers Blood Pressure Safely in Clinical Trial

New triple single-pill treatment lowers BP effectively and safely, simplifying early hypertension management in clinical practice.

Impact of Heart Age on Treatment Decisions in 370,000 Primary Care Patients

Using heart age to guide treatment decisions could lead to inappropriate care, impacting both younger and older patients.

Elevated NT-proBNP Linked to Higher Atrial Fibrillation Risk

NT-proBNP strongly predicts atrial fibrillation risk, particularly in older adults, with implications for improved risk stratification.

Festive Replay: 2024’s Healthcare Highlights Part 1

Evgenia Koutsouki, EMJ Editor, reflects on the most memorable moments from the EMJ Podcast over the past year in this festive highlights episode.

Reducing the CV Risks of Smoking

Smoking is a major risk factor for cardiovascular disease (CVD) and responsible for around 25% of all CVD-related deaths worldwide…

Loading posts...

« Previous 1 … 22 23 24 25 26 … 96 Next »